Citigroup Inc Sop Hi A Genetics Sa Transaction History
Citigroup Inc
- $169 Billion
- Q3 2024
A detailed history of Citigroup Inc transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Citigroup Inc holds 15 shares of SOPH stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 15
-0.0%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SOPH
# of Institutions
35Shares Held
18.6MCall Options Held
5.9KPut Options Held
300-
Generation Investment Management LLP London, X06.79MShares$22.5 Million0.12% of portfolio
-
Banque Pictet & Cie Sa2.24MShares$7.43 Million0.06% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$7.41 Million0.07% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL2.22MShares$7.35 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$7.17 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $212M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...